despit disappoint short-term prospect michael
stock soar sinc announc last week
test reduced-cholesterol egg product runup
much $ 20.50 pre-announc price $ 15.375 ad
near $ 100 million compani market capit
although michael announc custom
product yet
analyst skeptic increas
justifi multipl one assum
hitch new product delay
certif plant product merril lynch
capit market analyst leonard teitelbaum said
vulner
mr. teitelbaum whose rate stock neutral
trim estim year rang $ 1.10
$ 1.15 share first quarter expect earn
18 20 cent share compar 34 cent share
last year three million fewer share
outstand
analyst paul shain robert baird co. milwauke say
cut 1992 estim $ 1.05 share $ 1.20
margin deterior compani
commodity-bas busi michael squeez
kraft general food lower price chees mr. shain
forese letup second half
prospect simpli egg reduced-cholesterol
product develop mr. shain say near-term peopl
need realist predict volum happen
much cost develop easi
runup justifi given market re probabl
say ad scratch head person
want littl cautious
michael said intend sell simpli egg food
manufactur restaur food-servic custom
retail market competit
reduced-cholesterol egg-substitut product
market
compani say plan market product even
receiv food drug administr approv
process cholesterol remov yolk
fda later decid process substanc
beta-cyclodextrin safe could order product
recal compani file petit request
agenc find substanc safe human consumpt
ronald strauss follow michael food william
blair co. chicago advis client key question
simpli egg whether contribut better
nutrit answer extent
one might think say analyst say product
elimin cholesterol egg-white-bas
product
year result mr. strauss say remain
cautious compani earn first nine
month estim 90 cent share full year
assum simpli egg drag earn
amount cent per share year recoveri
next year seem reason say
